QQQ $ 601.82 $ -2.05 (-0.34 %)
DIA $ 463.14 $ -1.59 (-0.34 %)
SPY $ 664.20 $ -2.58 (-0.39 %)
TLT $ 90.71 $ -0.25 (-0.27 %)
GLD $ 386.06 $ 0.13 (0.03 %)
$ 15.29
-- x --
-- x --
-- - --
$ 11.25 - $ 15.82
187,745
na
nm
$ 0.36
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 kkr-outbids-competitors-to-secure-29-billion-karo-healthcare-takeover

KKR is closing in on a $2.9B takeover of Karo Healthcare after outbidding rivals, reinforcing its aggressive push into European...

 fda-wants-to-pull-popular-otc-decongestant-used-for-common-cold-over-effectiveness-concerns

FDA proposes removing oral phenylephrine from OTC drugs for nasal congestion, citing ineffectiveness. Public comments open befo...

Core News & Articles

Abbott Laboratories and a unit of Reckitt Benckiser Group Plc were cleared by a jury over claims they hid risks their premature...

 abbott-laboratories-attractive-valuation-ranks-it-among-top-large-cap-medtech-companies-says-analyst

Piper Sandler initiates coverage on Abbott with an Overweight rating, citing its diversified business model, strong medtech gro...

 consumer-giant-reckitt-seeks-help-from-investment-banks-to-evaluate-options-for-homecare-brands-baby-formula

Reckitt Benckiser is reportedly in early talks to sell its homecare division, featuring brands like Air Wick and Calgon, as par...

Core News & Articles

-Bloomberg

 abbott-laboratories-tumble-nearly-8-in-pre-market-after-us-jury-charges-495m-penalty-for-disease-causing-baby-formula

This verdict is part of nearly 1,000 lawsuits filed against Abbott Labs, its British rival Reckitt Benckiser, or both, in U.S. ...

 similac-baby-formula-maker-abbott-and-reckitt-face-hundreds-of-baby-formula-lawsuits

Abbott faces trial over claims its baby formula causes necrotizing enterocolitis in preterm infants. This is the second trial a...

 whats-going-on-with-abbott-laboratories-stock-on-friday

An Illinois jury orders Reckitt Benckiser's Mead Johnson to pay $60 million after a premature infant's tragic death lin...

 durex-owner-reckitt-benckiser-taps-into-chinas-livestreaming-trend-to-sell-condoms-online

Reckitt Benckiser Group is leveraging the popularity of livestream shopping in China to sell condoms, a move that could be chal...

 reckitts-mead-johnson-initiates-massive-recall-of-675k-cans-of-hypoallergenic-baby-formula-over-bacteria-contamination-fears

A massive recall of hypoallergenic infant formula has been initiated due to concerns over potential bacteria contamination. The...

 fda-panel-says-popular-otc-cold-allergy-medicine-might-be-useless---stocks-to-watch

According to FDA panel experts who reviewed the latest research on the long-questioned phenylephrine, a drug ingredient used in...

 abbott-laboratories-under-doj-investigation-into-2022-baby-formula-plant-shutdown-report

The Justice Department's consumer-protection branch is conducting an investigation into infant formula maker Abbott Laborat...

 short-volatility-alert-reckitt-benckiser-group-plc

On Friday, shares of Reckitt Benckiser Group plc (OTC: RBGLY) experienced volatile short activity. After the activity, the stoc...

 new-starbucks-ceo-to-focus-on-unions-pay-and-benefits-as-part-of-reinvention-plan

Starbucks Corporation (NYSE: SBUX) surprised everyone this week by naming Reckitt Benckiser Group plc (OTC: RBGLY)

 why-this-starbucks-analyst-is-surprised-by-new-ceo-choice--and-optimistic

Starbucks Corporation (NYSE: SBUX) announced late Thursday the appointment of Reckitt Benckiser Group plc (OTC: RBGLY) top brass

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION